A first tire member manufacturing method includes an operation in which a master batch is made, and an operation in which the master batch, peptizing agent, and processing additive are mixed. The operation in which the master batch is made includes an operation in which carbon-black-containing pre-coagulation rubber latex is coagulated to obtain a coagulum, an operation in which a compound according to Formula (I), below, is added to the water-containing coagulum, and an operation in which the compound according to Formula (I) is dispersed within the coagulum.

##STR00001##

In Formula (I), R.sup.1 and R.sup.2 each indicates a hydrogen atom, an alkyl group having 1 to 20 carbons, an alkenyl group having 1 to 20 carbons, or an alkynyl group having 1 to 20 carbons. R.sup.1 and R.sup.2 may be the same or different. M.sup.+ indicates sodium ion, potassium ion, or lithium ion.

A first tire member manufacturing method includes an operation in which a master batch is made, and an operation in which the master batch, peptizing agent, and processing additive are mixed. The operation in which the master batch is made includes an operation in which carbon-black-containing pre-coagulation rubber latex is coagulated to obtain a coagulum, an operation in which a compound according to Formula (I), below, is added to the water-containing coagulum, and an operation in which the compound according to Formula (I) is dispersed within the coagulum.

##STR00001##

In Formula (I), R.sup.1 and R.sup.2 each indicates a hydrogen atom, an alkyl group having 1 to 20 carbons, an alkenyl group having 1 to 20 carbons, or an alkynyl group having 1 to 20 carbons. R.sup.1 and R.sup.2 may be the same or different. M.sup.+ indicates sodium ion, potassium ion, or lithium ion.

The present invention relates to cyclopropyl derivatives of general formula (I), wherein A, R.sup.1, and R.sup.2 are as defined in the specification. The present application also relates to pharmaceutical compositions containing such compounds and to their use in therapy. ##STR00001##

The present invention relates to cyclopropyl derivatives of general formula (I), wherein A, R.sup.1, and R.sup.2 are as defined in the specification. The present application also relates to pharmaceutical compositions containing such compounds and to their use in therapy. ##STR00001##

A process for preparing an acrylamide-based crosslinking monomer including reacting in the presence of a catalyst an isocyanate compound containing at least two isocyanate groups with one of acrylic acid and methacrylic acid.

A process for preparing an acrylamide-based crosslinking monomer including reacting in the presence of a catalyst an isocyanate compound containing at least two isocyanate groups with one of acrylic acid and methacrylic acid.

A process for preparing an acrylamide-based crosslinking monomer including reacting in the presence of a catalyst an isocyanate compound containing at least two isocyanate groups with one of acrylic acid and methacrylic acid.

A compound represented by Chemical Formula 1 or 2 of the present invention, or a pharmaceutically acceptable salt thereof can be used favorably for preventing or treating cancer or tumors.

A monomer composition for a dental material containing a (meth)acrylamide compound (A) including a cyclic structure and a (meth)acrylamide group.

A monomer composition for a dental material containing a (meth)acrylamide compound (A) including a cyclic structure and a (meth)acrylamide group.